Synonyms: LY-3303560 | LY3303560
Compound class:
Antibody
Comment: LY3303560 is a monoclonal antibody that selectively targets tau protein aggregates [1]. It is being developed by Eli Lilly for potential to treat Alzheimer's disease. The primary epitope for LY3303560 is located in the N-terminal region of tau.
|
Classification ![]() |
|
Compound class | Antibody |
International Nonproprietary Names ![]() |
|
INN number | INN |
11050 | zagotenemab |
Synonyms ![]() |
LY-3303560 | LY3303560 |
Database Links ![]() |
|
GtoPdb PubChem SID | 385612231 |
Search PubMed clinical trials | zagotenemab |
Search PubMed titles | zagotenemab |
Search PubMed titles/abstracts | zagotenemab |